Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of

First Page		Document Content
Date: 2015-01-11 09:20:52 Pfizer Cytomegalovirus vaccine Viral diseases Zurich Cantonal Bank Human cytomegalovirus Medicine Health Biology Vaccines Corporate crime Dow Jones Industrial Average		Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of Add to Reading List Source URL: www.redbiotec.ch Download Document from Source Website File Size: 179,49 KB Share Document on Facebook

	Pfandbriefzentrale der schweizerischen Kantonalbanken DocID: 1pHwP - View Document
	Microsoft Word - mimeattach8067.doc DocID: SpmK - View Document
	The Zurich banking centre Facts and figures[removed]edition Foreword DocID: SauZ - View Document
	20150222_Oerlikon Consensus FY 2014_Extern DocID: S8Ka - View Document
	Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of DocID: QQHq - View Document